Global Precision Medicine Market - Segmented by Technology, by Application, Geography - Growth, Trends, and Forecast (2018 - 2023)

  • ID: 4520139
  • Report
  • Region: Global
  • 110 pages
  • Mordor Intelligence
1 of 4

FEATURED COMPANIES

  • EAGLE GENOMICS LTD
  • FERRER INCODE
  • INTOMICS
  • MEDTRONIC
  • NANOSTRING TECHNOLOGIES
  • NOVARTIS
  • MORE
The precision medicine market is expected to witness a CAGR of 9.7% during the forecast period. North America dominates the global market due to high incidence of cancer and government initiatives in the region.

Increasing Online Collaborative Forums

Precision medicine is based on the genetic profile of a patient and the way a particular drug can work for a specific genetic type. Drug development and discovery in precision medicine requires a collaborative effort. The data from clinical research and other gene sequencing forums are important in understanding the drug targets for personalized medicine. Sharing the information available through online collaborations helps in exchanging useful information between different research groups, thus, increasing online collaborative forums, which is further fuelling the growth of the global precision medicine market.

Additionally, increasing efforts to characterize genes and advancement in cancer biology are also responsible for the growth of the global precision medicine market.

Perils of Data Sharing

Expansion of healthcare with huge volume and velocity of data has encouraged clinicians and hospitals to use analytics. In spite of all the benefits provided by healthcare analytics there are still barriers to adopt healthcare IT systems; data integrity is one such barrier. Well-established organizations are facing difficulty in capturing data from different sources. Data integrity has been impacted by duplicate records and patient misidentification. Criminals are stealing information through breached cyber security (identity theft) to reach beyond the victim’s bank accounts. The integrity of data in health IT systems can also be compromised due to data entry errors, missing data or delayed data delivery, copying and pasting older information into a new report, use of both paper and electronic systems for patient care, and patient/data association errors. Since inaccurate data has the potential to become a major health risk for patients and a huge liability for providers, it is a key factor restraining the growth of the precision medicine market.

Additionally, high cost associated with precision medicine and declining trends in FDA Pharmacotherapy approval rate are restraining the growth of the global precision medicine market.

North America Dominating the Market

The precision medicine market is expected to witness a CAGR of 9.7% during the forecast period. The US precision medicine market accounted for the largest regional share in 2017, owing to high prevalence of cancer, coupled with favorable regulatory scenario in the country. Numerous awareness campaigns and initiatives organized by government and private associations and societies, to increase awareness levels, will propel industry expansion. For example, the launch of Precision Medicine Initiative (PMI) by President Barack Obama in 2015 for developing innovative solutions for chronic diseases, such as cancer, based on genomic, environment and lifestyle characteristics of patients will also fuel the regional market growth.

Key Developments in the Market
  • March 2017: NanoString launched nCounter Low RNA Input Kit, a product that generates high-quality gene expression profiling of up to 800 gene targets from as little as 1 ng of sample
Major Players: BIOCRATES LIFE SCIENCES AG, NANOSTRING TECHNOLOGIES, INTOMICS, FERRER INCODE, PFIZER, EAGLE GENOMICS LTD, TEVA PHARMACEUTICALS, LABORATORY CORPORATION OF AMERICA HOLDINGS, MEDTRONIC, NOVARTIS, QIAGEN, QUEST DIAGNOSTICS, and ROCHE HOLDING AG, AMONGST OTHERS.

Reasons to Purchase the Report
  • Current and future precision medicine market outlook in the developed and emerging markets
  • Analyzing various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3 month analyst support, along with the Market Estimate sheet (in Excel).
Customization of the Report

This report can be customized to meet your requirements. Please contact us for more information.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • EAGLE GENOMICS LTD
  • FERRER INCODE
  • INTOMICS
  • MEDTRONIC
  • NANOSTRING TECHNOLOGIES
  • NOVARTIS
  • MORE
1. Introduction
1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview
5.1 Current Market Scenario
5.2 Porters Five Forces
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry

6. Drivers, Restraints, Opportunities And Challenges Analysis (DROC)
6.1 Market Driver
6.1.1 Increasing Online Collaborative Forums
6.1.2 Increasing Efforts to Characterize Genes
6.1.3 Advancement in Cancer Biology
6.2 Market Restraints
6.2.1 Perils of Data Sharing
6.2.2 High Cost Associated with Precision Medicine
6.2.3 Declining Trends in FDA Pharmacotherapy Approval rate
6.3 Opportunities
6.4 Key Challenges

7. Market Segmentation
7.1 By Technology
7.1.1 Big Data Analytics
7.1.2 Bioinformatics
7.1.3 Gene Sequencing
7.1.4 Drug Discovery
7.1.5 Companion Diagnostics
7.1.6 Others
7.2 By Application
7.2.1 Oncology
7.2.2 CNS
7.2.3 Immunology
7.2.4 Respiratory
7.2.5 Others
7.3 By Geography
7.3.1 North America
7.3.1.1 United States
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 Europe
7.3.2.1 France
7.3.2.2 Germany
7.3.2.3 United Kingdom
7.3.2.4 Italy
7.3.2.5 Spain
7.3.2.6 Rest of Europe
7.3.3 Asia-Pacific
7.3.3.1 China
7.3.3.2 Japan
7.3.3.3 India
7.3.3.4 Australia & New Zealand
7.3.3.5 South Korea
7.3.3.6 Rest of Asia-Pacific
7.3.4 Middle East & Africa
7.3.4.1 GCC
7.3.4.2 South Africa
7.3.4.3 Rest of Middle East & Africa
7.3.5 South America
7.3.5.1 Brazil
7.3.5.2 Argentina
7.3.5.3 Rest of South America

8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations & Partnerships
8.3 New Products Launches

9. Key Players
9.1 Biocrates Life Sciences Ag
9.2 Nanostring Technologies
9.3 Intomics
9.4 Ferrer Incode
9.5 Pfizer
9.6 Eagle Genomics Ltd
9.7 Teva Pharmaceuticals
9.8 Laboratory Corporation of America Holdings
9.9 Medtronic
9.10 Novartis
9.11 Qiagen
9.12 Quest Diagnostics
9.13 Roche Holding Ag

10. Future Outlook of the Market
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • BIOCRATES LIFE SCIENCES AG
  • NANOSTRING TECHNOLOGIES
  • INTOMICS
  • FERRER INCODE
  • PFIZER
  • EAGLE GENOMICS LTD
  • TEVA PHARMACEUTICALS
  • LABORATORY CORPORATION OF AMERICA HOLDINGS
  • MEDTRONIC
  • NOVARTIS
  • QIAGEN
  • QUEST DIAGNOSTICS
  • ROCHE HOLDING AG
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll